Abstract
Fullerenes as a unique class of carbon allotropes have been studied extensively for their distinctive material properties and potential technological applications, including those in biology and medicine. Since a major focus in the latter has been on drug development and formulation, in this paper we highlight some representative studies related to such a focus, including the use of fullerenes for drug-like functions and for their improving the formulation of established drugs. Also discussed are some other potential medically relevant applications of fullerenes, such as their serving as potent agents in photodynamic therapy and magnetic imaging.
Keywords: Fullerenes, radical scavengers, drug carriers, photodynamic therapy, endofullerenes, MRI contrast agents, carbon allotropes, technological applications, amino acid, carboxylic acid, amphiphilic polymers
Current Medicinal Chemistry
Title: Fullerenes for Applications in Biology and Medicine
Volume: 18 Issue: 14
Author(s): P. Anilkumar, F. Lu, L. Cao, P. G. Luo, J.-H. Liu, S. Sahu, K. N. Tackett II, Y. Wang and Y.-P. Sun
Affiliation:
Keywords: Fullerenes, radical scavengers, drug carriers, photodynamic therapy, endofullerenes, MRI contrast agents, carbon allotropes, technological applications, amino acid, carboxylic acid, amphiphilic polymers
Abstract: Fullerenes as a unique class of carbon allotropes have been studied extensively for their distinctive material properties and potential technological applications, including those in biology and medicine. Since a major focus in the latter has been on drug development and formulation, in this paper we highlight some representative studies related to such a focus, including the use of fullerenes for drug-like functions and for their improving the formulation of established drugs. Also discussed are some other potential medically relevant applications of fullerenes, such as their serving as potent agents in photodynamic therapy and magnetic imaging.
Export Options
About this article
Cite this article as:
Anilkumar P., Lu F., Cao L., G. Luo P., Liu J.-H., Sahu S., N. Tackett II K., Wang Y. and Sun Y.-P., Fullerenes for Applications in Biology and Medicine, Current Medicinal Chemistry 2011; 18 (14) . https://dx.doi.org/10.2174/092986711795656225
DOI https://dx.doi.org/10.2174/092986711795656225 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Targets for Promoting Wound Healing in Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Graphical Abstracts
Letters in Drug Design & Discovery Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?
Reviews on Recent Clinical Trials Epothilones: From Discovery to Clinical Trials
Current Topics in Medicinal Chemistry Genetics of Serotonin Receptors and Depression: State of the Art
Current Drug Targets Histamine H4 Receptor: A Novel Therapeutic Target for Immune and Allergic Responses
Mini-Reviews in Medicinal Chemistry Application, Reactivity and Synthesis of Isoxazole Derivatives
Mini-Reviews in Organic Chemistry A Hypothesis for the Relationship between Depression and Cancer: Role of Ca2+/cAMP Signalling
Anti-Cancer Agents in Medicinal Chemistry A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility
CNS & Neurological Disorders - Drug Targets Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach
Mini-Reviews in Medicinal Chemistry Ubiquitylation and Cancer Development
Current Cancer Drug Targets Antibody-Drug Conjugate Targets
Current Cancer Drug Targets Use of Mesenchymal Stem Cells in Crohn's Disease and Perianal Fistulas: A Narrative Review
Current Stem Cell Research & Therapy Synthesis and Biological Evaluation of Triazole-Vanillin Molecular Hybrids as Anti-Cancer Agents
Current Bioactive Compounds Cross Talks Between Oncoprotein Signaling Networks and Tumor Suppressor p53 in Breast Cancer
Current Cancer Therapy Reviews Subject Index To Volume-3
Letters in Drug Design & Discovery Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Synthesis of Monosulfated Lewis a Trisaccharide Library Through Sulfation of a Partial Protected Trisaccharide
Letters in Organic Chemistry Therapeutic Antibodies and Other Proteins Obtained by Molecular Display Technologies
Recent Patents on Biotechnology Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics
Current Medicinal Chemistry